Prasad Raju

Chief Financial OfficerCRISPR Therapeutics AG (CRSP) · full profile →Form 4 · filed Jan 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2026Option exercise(M)23K$45.15$1.1M30K
Jan 6, 2026Option exercise(M)6K$44.31$281K36K
Jan 6, 2026Sell(S)6K$60.21$347K7K
Jan 6, 2026Sell(S)5K$60.00$300K13K
Jan 6, 2026Sell(S)19K$60.18$1.1M18K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 6, 2026Option exercise(M)23K$077K
Jan 6, 2026Option exercise(M)6K$07K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-007875) within minutes of acceptance. Every field above traces to the original document. Verify it directly: